You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DB11

Showing 1 - 25 of 3,781
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)

Completed
Has Results
  • Migraine Headache
  • DFN-15 Active
  • DFN-15 Placebo
  • Birmingham, Alabama
  • +44 more
Dec 15, 2022

Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)

Completed
Has Results
  • Migraine Headache
  • DFN-15 Active
  • DFN-15 Placebo
  • Birmingham, Alabama
  • +42 more
Dec 15, 2022

Premature Infant Disease Trial in Genova (White Noises and Maternal and/or Paternal voices)

Not yet recruiting
  • Premature Infant Disease
  • White Noises and Maternal and/or Paternal voices
  • Genova, Italy
    IRCCS Istituto Giannina Gaslini
Nov 20, 2023

Asthma Trial in Worldwide (Benralizumab, Placebo)

Not yet recruiting
  • Asthma
  • Owensboro, Kentucky
  • +6 more
Jan 11, 2023

Cohort Of DEafness-gene Screening

Active, not recruiting
  • Hearing Loss
  • Genetic screening test (Deafness gene variant detection array kit)
  • (no location specified)
Nov 10, 2023

Otosclerosis of Middle Ear Trial in Mansoura (Endoscopic classic stapedotomy, Endoscopic reversal stapedotomy)

Completed
  • Otosclerosis of Middle Ear
  • Endoscopic classic stapedotomy
  • Endoscopic reversal stapedotomy
  • Mansoura, Dakahlia Governorate, Egypt
    Mansoura University Hospitals
Oct 28, 2022

Type 2 Diabetes Trial in Taipei City (Personalized Diabetes Text Messaging (DB-TEXT) combined with Peer Support Education,

Not yet recruiting
  • Type 2 Diabetes
  • Personalized Diabetes Text Messaging (DB-TEXT) combined with Peer Support Education
  • Personalized Diabetes Text Messaging (DB-TEXT)
  • Taipei City, Xinyi District, Taiwan
    Taipei Medical University
Nov 28, 2022

Cognitive Reserve Disorder Affecting Depression in Aged Related

Active, not recruiting
  • Age-related Hearing Loss
  • +2 more
  • with depression
  • without depression
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 6, 2023

Brown Adipose Tissue Activity in Response to Semaglutide

Not yet recruiting
  • Obesity
  • Semaglutide Injectable Product
  • (no location specified)
Jan 17, 2023

Brain Network of Otologic and Cognitive Function With

Completed
  • COVID-19
  • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Mar 26, 2023

    Atopic Dermatitis Trial in Worldwide (DUPILUMAB, PLACEBO)

    Completed
    Has Results
    • Atopic Dermatitis
    • North Little Rock, Arkansas
    • +41 more
    Oct 5, 2022

    Type 1 Diabetes Trial (Tandem t:slim X2 with Control-IQ Technology, Sensor augmented pump (SAP) therapy)

    Not yet recruiting
    • Type 1 Diabetes
    • Tandem t:slim X2 with Control-IQ Technology
    • Sensor augmented pump (SAP) therapy
    • (no location specified)
    Dec 15, 2022

    Bietti Crystalline Dystrophy Trial in Shanghai (VGR-R01)

    Not yet recruiting
    • Bietti Crystalline Dystrophy
    • VGR-R01
    • Shanghai, Shanghai, China
      Shanghai Vitalgen Biopharma Co.,Ltd.
    Jan 20, 2023

    Aging Trial in Orlando (Maximal oxygen consumption (V02 max), Brown adipose tissue (BAT) imaging, Muscle function testing)

    Active, not recruiting
    • Aging
    • Maximal oxygen consumption (V02 max)
    • +2 more
    • Orlando, Florida
      Translational Research Institute for Metabolism and Diabetes
    Nov 16, 2022

    Breast Cancer Trial in Shanghai (axillary surgery de-escalation after NAT)

    Recruiting
    • Breast Cancer
    • axillary surgery de-escalation after NAT
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Jun 13, 2023

    Double-bundle Posterior Cruciate Ligament Reconstruction

    Recruiting
    • Posterior Cruciate Ligament Tear
    • DB-PCLR
    • Bełchatów, Łódzkie, Poland
      Artromedical Orthopaedic Clinic
    Jan 25, 2023

    Language Development Disorders Trial in Clermont-Ferrand (acoustic otoemisions, Otoscopy, Audiometry)

    Not yet recruiting
    • Language Development Disorders
    • acoustic otoemisions
    • +3 more
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand, UMR INSERM 1107
    Nov 21, 2022

    Hearing Impairment Trial in Macquarie (CP1170 sound processor, CP1150 Sound processor)

    Recruiting
    • Hearing Impairment
    • CP1170 sound processor
    • CP1150 Sound processor
    • Macquarie, Sydney, Australia
      Cochlear Macquarie
    Jan 9, 2023

    Smoking Cessation, Weight Gain Trial (Smoking Cessation)

    Not yet recruiting
    • Smoking Cessation
    • Weight Gain
    • Smoking Cessation
    • (no location specified)
    Jul 10, 2022

    Myasthenia Gravis Trial in Worldwide (Tolebrutininb, Placebo)

    Recruiting
    • Myasthenia Gravis
    • Washington, District of Columbia
    • +22 more
    Dec 8, 2022

    Fatty Liver, NAFLD Trial (Coenzyme Q10 Forte® capsules)

    Not yet recruiting
    • Fatty Liver
    • NAFLD
    • Coenzyme Q10 Forte® capsules
    • (no location specified)
    Aug 8, 2023

    Rare Cancers, Multiomics Trial in Heidelberg

    Recruiting
    • Rare Cancers
    • Multiomics
      • Heidelberg, Germany
        German Cancer Research Center
      May 2, 2023

      Vascular Aging Trial in Milwaukee (Lactobacillus Plantarum 299v in fermented oat drink, Heat-Killed Placebo control fermented

      Not yet recruiting
      • Vascular Aging
      • Lactobacillus Plantarum 299v in fermented oat drink
      • Heat-Killed Placebo control fermented drink
      • Milwaukee, Wisconsin
        Medical College of Wisconsin
      Oct 11, 2022

      Glabellar Lines Trial in France, Germany, United Kingdom (Botulinum toxin type A, Placebo)

      Completed
      Has Results
      • Glabellar Lines
      • Botulinum toxin type A
      • Placebo
      • Arras, France
      • +23 more
      Sep 15, 2022

      Conductive Hearing Loss, Mixed Hearing Loss Trial in Gothenburg (Sentio 1)

      Recruiting
      • Conductive Hearing Loss
      • Mixed Hearing Loss
      • Sentio 1
      • Gothenburg, Sweden
        Habilitation & Health, Hearing organization
      Nov 29, 2022